Cause of death, by non-communicable diseases, ages 0-4, female in Czechia
Czechia: Cause of death, by non-communicable diseases, ages 0-4, female was 32.0% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 0-4, female in Czechia, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
Czechia recorded 32.0% for cause of death, by non-communicable diseases, ages 0-4, female in 2021.
The figure is up 0.5% on the previous year and down 9.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Czechia peaked at 35.6% in 2015 and was at its lowest, 31.9%, in 2020.
Czechia ranks 86th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, female in Czechia, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 32.5% | — |
| 2010 | 35.4% | +9.1% |
| 2015 | 35.6% | +0.5% |
| 2019 | 34.5% | -2.9% |
| 2020 | 31.9% | -7.8% |
| 2021 | 32.0% | +0.5% |
Czechia compared with similar countries
- Czechia's 32.0% is below the median for high income countries, which is 42.8%, 75% of the median. (58 countries reporting)
- Czechia's 32.0% is below the median for Europe & Central Asia, which is 39.9%, 80% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.5% | 32.5% | 32.5% | 1 |
| 2010s | 35.2% | 34.5% | 35.6% | 3 |
| 2020s | 32.0% | 31.9% | 32.0% | 2 |
Countries ranked near Czechia
More health data for Czechia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.7726 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,169 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0222 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.46 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Czechia?
- Cause of death, by non-communicable diseases, ages 0-4, female in Czechia was 32.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Czechia?
- The highest recorded value was 35.6% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Czechia?
- The lowest recorded value was 31.9% in 2020.
- How does Czechia rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Czechia ranks 86th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Czechia?
- Over the last ten years it is down 9.5%. The long-run trend across the full record is flat.
- Where does this Czechia data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.